| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |